| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 76,087 | $8,217,396 | $108.00 | 15 Nov 2021 | Direct |
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 1,543 | $166,644 | $108.00 | 15 Nov 2021 | Profit Sharing Trust |
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Option (right to buy) | 0 | 27 Aug 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 15 Nov 2021 | 1 | -$1,300,090 | 4 | EXECUTIVE VICE PRESIDENT | 17 Nov 2021, 17:22 |
| ABT | ABBOTT LABORATORIES | 27 Aug 2021 | 3 | -$11,835,669 | 4 | EXECUTIVE VICE PRESIDENT | 31 Aug 2021, 17:18 |